Please assess the completion status of the following clinical trial:

Trial Title: MOnitoring REsynchronization deviCes and cARdiac patiEnts

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient indicated to CRT-ICD according to current guidelines:~* Left ventricular systolic dysfunction (LVEF≤35%),~* New York Heart Association functional class III-IV,~* QRS≥120 ms~* Optimized medical treatment.~* Patient implanted within the last 8 weeks with Medtronic CRT-ICD device equipped with fluid accumulation diagnostics, AT/AF monitoring capability, wireless telemetry for automatic remote data transmission and alerting system for physician.~* Patient with less than 8 weeks follow-up, who has not received Carelink® Network Monitor and was not managed by Cardiac Compass report reviewing.~* Carelink Network is available at patient's home~* Patient or the patient's caregiver is willing and able to use the Medtronic CareLink® Network Monitor and to perform the required duties at home or has a family member or assistant perform those duties.~* Patient is willing and able to sign an informed consent form.~Exclusion Criteria:~* Inability to fully understand the instructions relating to remote monitoring using CareLink® Network.~* Permanent AT/AF.~* Patient had not been previously implanted with a CRT/CRT-D device.~* Patient has medical conditions that would limit study participation.~* Patient is less than 18 years of age.~* Patient is enrolled in or intends to participate in another clinical trial that may have an impact on the study endpoints.~* Patient meets any exclusion criteria required by local law.~* Inability or refusal to sign a patient informed consent form.~* Patient's life expectancy is less than one year in the opinion of the physician~* Patient is pregnant or breastfeeding.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Study Group (Type: ACTIVE_COMPARATOR): Patients of the study arm are CRT-D patients followed-up by means of a remote disease management system (Medtronic Carelink® Network), for which an automatic alerting system is enabled for fluid accumulation, AT/AF episodes and system integrity.
- Control Group (Type: NO_INTERVENTION): Patients are CRT-D patients managed according to current standard clinical practice, based on routinely performed in-office visits.

Based on this trial design, predict the completion outcome and termination type (if applicable).